Mayer Arie — SEC insider filings
SEC reporting owner CIK 1796583. 10 insider filings on record with FilingPulse; latest filed 2026-11-13.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2022-01-05 to 2026-11-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 1 filing — 8,809 shares, $19,518 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 3,000 shares, $76,800 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: sale of 3,000 shares @ $25.60 ($76,800) in ORAMED PHARMACEUTICALS INC., filed 2022-05-10.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. (ORMP) | Director | 10 | 2 legs · 8,809 sh · $19,518 | 1 leg · 3,000 sh · $76,800 | 13 |
Insider filings — Mayer Arie
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-13 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 72,780 · Grant/award (A): 1,470 | EDGAR |
| 2026-01-05 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 30,000 · Grant/award (A): 4,900 | EDGAR |
| 2025-06-09 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 30,000 · Grant/award (A): 6,975 | EDGAR |
| 2024-01-08 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 30,000 · Grant/award (A): 9,325 | EDGAR |
| 2023-04-20 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 30,000 | EDGAR |
| 2023-04-04 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Purchase (P): 5,009 @ $2.22 · Purchase (P): 3,800 @ $2.21 | EDGAR |
| 2022-08-01 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 12,000 | EDGAR |
| 2022-05-10 | 4/A | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 6,000 | EDGAR |
| 2022-05-10 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Sale (S): 3,000 @ $25.60 | EDGAR |
| 2022-01-05 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 6,000 · Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1796583 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs